<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Karere GM</submitter><funding>American Heart Association</funding><funding>NCRR NIH HHS</funding><funding>American Heart Association-American Stroke Association</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>3467</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977938</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Identification of potential therapeutic targets and biomarkers indicative of burden of early atherosclerosis that occur prior to advancement to life-threatening unstable plaques is the key to eradication of CAD prevalence and incidences. We challenged 16 baboons with a high cholesterol, high fat diet for 2 years and evaluated early-stage atherosclerotic lesions (fatty streaks, FS, and fibrous plaques, FP) in formalin-fixed common iliac arteries (CIA). We used small RNA sequencing to identify expressed miRNAs in CIA and in baseline blood samples of the same animals. We found 412 expressed miRNAs in CIA and 356 in blood samples. Eight miRNAs (miR-7975, -486-5p, -451a, -191-5p, -148a-3p, -17-5p, -378c, and -144-3p) were differentially expressed between paired fatty streak lesion and no-lesion</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions.</pubmed_title><pmcid>PMC9977938</pmcid><funding_grant_id>P51 RR013986</funding_grant_id><funding_grant_id>P01 HL028972</funding_grant_id><funding_grant_id>C06 RR014578</funding_grant_id><funding_grant_id>K01 HL130697</funding_grant_id><funding_grant_id>C06 RR017515</funding_grant_id><funding_grant_id>P51 OD011133</funding_grant_id><funding_grant_id>C06 RR015456</funding_grant_id><funding_grant_id>C06 RR013556</funding_grant_id><funding_grant_id>K01HL130697</funding_grant_id><funding_grant_id>4POST18150019</funding_grant_id><funding_grant_id>P01HL028972</funding_grant_id><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Konar A</pubmed_authors><pubmed_authors>VandeBerg JL</pubmed_authors><pubmed_authors>Glenn JP</pubmed_authors><pubmed_authors>Karere GM</pubmed_authors><pubmed_authors>Cox LA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions.</name><description>Identification of potential therapeutic targets and biomarkers indicative of burden of early atherosclerosis that occur prior to advancement to life-threatening unstable plaques is the key to eradication of CAD prevalence and incidences. We challenged 16 baboons with a high cholesterol, high fat diet for 2 years and evaluated early-stage atherosclerotic lesions (fatty streaks, FS, and fibrous plaques, FP) in formalin-fixed common iliac arteries (CIA). We used small RNA sequencing to identify expressed miRNAs in CIA and in baseline blood samples of the same animals. We found 412 expressed miRNAs in CIA and 356 in blood samples. Eight miRNAs (miR-7975, -486-5p, -451a, -191-5p, -148a-3p, -17-5p, -378c, and -144-3p) were differentially expressed between paired fatty streak lesion and no-lesion</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T20:10:10.723Z</modification><creation>2025-04-04T20:10:10.723Z</creation></dates><accession>S-EPMC9977938</accession><cross_references><pubmed>36859458</pubmed><doi>10.1038/s41598-023-29074-1</doi></cross_references></HashMap>